Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-06-05FDA Approved: ARISTADA — Supplemental Application (Alkermes, Inc.)
The FDA is reviewing a supplemental application for ARISTADA (aripiprazole lauroxil) submitted by Alkermes, Inc. for potential changes or ad…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Cerebellar rTMS for the Treatment of Schizophrenic Patients [NA]
An update on a completed clinical trial evaluating cerebellar repetitive transcranial magnetic stimulation as a treatment for schizophrenia.…
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Therapeutic Efficacy of Transcranial Magnetic Stimulation in Schizophrenia [NA]
The completed clinical trial evaluating transcranial magnetic stimulation for schizophrenia has posted results.
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia [Phase 2]
Phase 2 trial comparing oxytocin or galantamine versus placebo for negative symptoms and cognitive impairment in schizophrenia; results post…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Oxytocin and Social Cognition in Schizophrenia [Phase 2]
Phase 2 trial update studying oxytocin's effects on social cognition in schizophrenia; results posted after completion.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-05-30Clinical Trial Update: Nicotinic Receptors and Schizophrenia [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating nicotinic receptor targets for schizophrenia has been withdrawn.
-
CLINICAL_TRIALS research · 2017-05-23Clinical Trial Update: Evaluation of Stroop Effect in Patients With Schizophrenia [NA]
This entry notes a clinical trial at University Hospital in Clermont-Ferrand evaluating the Stroop effect in individuals with schizophrenia,…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents [Phase 2]
Phase 2 study evaluating lurasidone in antipsychotic-naive or quasi-naive children and adolescents with schizophrenia-spectrum and mood diso…
-
FDA approval · 2017-05-17FDA Approved: QUETIAPINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' generic quetiapine (quetiapine) for the treatment of schizophrenia and bipolar disorder, expanding acces…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Effects of Eszopiclone on Sleep and Memory in Schizophrenia [NA]
A completed clinical trial evaluated the effects of eszopiclone on sleep and memory in people with schizophrenia; results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Electronic Cigarettes in Smokers With Mental Illness [NA]
A completed clinical trial investigating electronic cigarettes in smokers with mental illness; the summary does not provide trial results.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia [Phase 2]
Phase 2 trial comparing varenicline to placebo for smoking cessation in individuals with schizophrenia; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy Motivation [NA]
Clinical trial update noting that the study on resource-oriented music therapy for psychiatric patients with low motivation has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Relationship Between Neurotransmitter Receptor Polymorphisms, Plasma Concentrations and Clinical Response to Clozapine
This completed trial examined how neurotransmitter receptor polymorphisms and Clozapine plasma levels relate to clinical response in schizop…
-
FDA approval · 2017-05-12FDA Approved: HALOPERIDOL DECANOATE — Original Application (Sagent Pharmaceuticals)
FDA approved haloperidol decanoate from Sagent Pharmaceuticals under the original application, a long-acting injectable antipsychotic.
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Employment Outcomes After Vocational Training [NA]
This completed clinical trial evaluated employment outcomes after vocational training for individuals with schizophrenia-related disorders a…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia [Phase 3]
This clinical trial update reports a Phase 3 study evaluating D-serine for negative symptoms and cognitive deficits in schizophrenia, with r…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia) [NA]
A clinical trial (RISE) evaluating rehabilitation interventions for people with schizophrenia in Ethiopia has completed.
-
FDA approval · 2017-05-09FDA Approved: QUETIAPINE FUMARATE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's generic quetiapine fumarate under Original Application (ANDA090681) to bring a quetiapine fumarate product …
-
CLINICAL_TRIALS research · 2017-05-09Clinical Trial Update: Evaluation of Executive Function With Virtual Reality Among People With Schizophrenia [NA]
The study investigates executive function in people with schizophrenia using virtual reality. The current status of the trial is unknown.
-
CLINICAL_TRIALS research · 2017-05-05Clinical Trial Update: 50 Hz vs. 25 Hz Magnetic Seizure Therapy for Schizophrenia [NA]
A completed clinical trial comparing 50 Hz versus 25 Hz Magnetic Seizure Therapy for schizophrenia.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Past Pain Experience and Perception of Experimental Pain
This completed clinical trial investigated how past pain experience relates to perceptions of experimental pain in individuals with schizoph…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia [Phase 1]
Phase 1 study evaluating TAK-058 and ondansetron on P50 auditory gating in participants with stable schizophrenia; the trial was terminated …
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: The Effects of Nicotine on Cognition in Schizophrenia [Phase 4]
Phase 4 clinical trial update examining the effects of nicotine on cognition in individuals with schizophrenia; results posted.
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study
A six-year follow-up update from a clinical trial studying anomalous self-experience in first-episode psychosis, reporting long-term outcome…